Skip to main content

Advertisement

Table 2 Cognitive test performances

From: The impact of homocysteine, B12, and D vitamins levels on functional neurocognitive performance in HIV-positive subjects

  Median (IQR) Normality Range/Cut-off Pathologic Test, n (%)
MEMORY    12 (21.1)*
 Rey BT 39.0 (34.0–44.0) > 28.53 9 (15.8)
 Rey LT 8.0 (6.0–10.0) > 4.69 11 (19.3)
ATTENTION AND WORKING MEMORY    38 (66.7)*
 Verbal Span forward 5.0 (4.0–6.0) 5.00–9.00 18 (31.6)
 Spatial Span forward 3.0 (3.0–5.0) 5.00–9.00 37 (64.9)
 Double barrage 1.0 (1.0–1.0) > 0.92 6 (10.5)
EXECUTIVE FUNCTIONS    33 (57.9)*
 Stroop E 1.0 (0–2.0) < 4.24 8 (14.0)
 Stroop T 19.0 (14.0–28.0) < 36.91 10 (17.5)
 Trail making test B - T 149.0 (112.0–220.0) 111.29″-248.89″ 10 (17.5)
 Trail making test B - E 1.0 (0–2.0) −0.21-2.39 6 (10.5)
 Drawings 5.0 (3.0–6.0) 3.85–6.15 16 (28.1)
 Wais Digit span 33.0 (23.0–45.0) > 6.00 14 (24.6)
LANGUAGE    5 (8.8)*
 Verbal fluency test 33.0 (27.0–41.0) > 17.35 5 (8.8)
SPEED OF PSYCHOMOTOR PROCESSING    18 (31.6)*
 Pegboard dom 72.0 (62.0–82.0) 55.94–74.32 18 (31.6)
 Pegboard non dom 75.0 (68.0–85.0) 59.68–80.30 10 (17.5)
DEPRESSION    12 (21.1)*
 Zung depression score 38.0 (31.0–46.0) < 50.00 12 (21.1)
DAILY LIFE ACTIVITY
 IADL 8.0 (8.0–8.0) < 7.00
  1. *Patients with at least one pathologic test in the relative domain. IQR Interquartile Range